SCHEMBL6268182

SCHEMBL6268182

CC(=O)O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CD69 Q07108 1/20 0.53
▸ MAPK1 P28482 1/20 0.46
▸ PYGB P11216 2/20 0.42
▸ LGALS8 O00214 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ SLC28A3 Q9HAS3 3/20 0.40
▸ GAA P10253 1/20 0.39
▸ PRKCA P17252 2/20 0.38
▸ PRKD3 O94806 1/20 0.38
▸ PRKCG P05129 1/20 0.38
▸ PRKCB P05771 1/20 0.38
▸ PRKCH P24723 1/20 0.38
▸ PRKCE Q02156 1/20 0.38
▸ PRKCQ Q04759 1/20 0.38
▸ PRKCD Q05655 1/20 0.38
▸ PRKD1 Q15139 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16683389 1.00 CD69 (0.53) CD69MAPK1PYGBLGALS8KDM4E
SCHEMBL2429109 1.00 CD69 (0.53) CD69MAPK1PYGBLGALS8KDM4E
SCHEMBL8021265 1.00 CD69 (0.53) CD69MAPK1PYGBLGALS8KDM4E
SCHEMBL7515919 1.00 CD69 (0.53) CD69MAPK1PYGBLGALS8KDM4E
SCHEMBL8166277 1.00 CD69 (0.53) CD69MAPK1PYGBLGALS8KDM4E
SCHEMBL8361872 1.00 CD69 (0.53) CD69MAPK1PYGBLGALS8KDM4E
SCHEMBL14414822 0.95 CD69 (0.48) CD69MAPK1PYGBLGALS8KDM4E
SCHEMBL6936528 0.95 CD69 (0.48) CD69MAPK1PYGBLGALS8KDM4E
SCHEMBL10022858 0.89 CD69 (0.47) CD69MAPK1PYGBLGALS8KDM4E
SCHEMBL16260821 0.89 CD69 (0.47) CD69MAPK1PYGBLGALS8KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2850084-A1 PYRAZOLE COMPOUNDS AS SGLT1 INHIBITORS Eli Lilly and Company (US) 2015-03-25 — — EP disclosed
WO-2013169546-A1 PYRAZOLE COMPOUNDS AS SGLT1 INHIBITORS ELI LILLY AND COMPANY (US) 2013-11-14 — — WO disclosed
EP-1270584-B1 GLUCOPYRANOSYLOXY BENZYLBENZENE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES FOR THE PREPARATION OF THE DERIVATIVES KISSEI PHARMACEUTICAL (JP) 2005-12-07 — — EP disclosed
EP-1329456-A1 GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME Kissei Pharmaceutical Co., Ltd. (JP) 2003-07-23 — — EP disclosed
EP-1270584-A1 GLUCOPYRANOSYLOXY BENZYLBENZENE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES FOR THE PREPARATION OF THE DERIVATIVES Kissei Pharmaceutical Co., Ltd. (JP) 2003-01-02 — — EP disclosed
EP-0816375-A1 GLYCOCONJUGATES OF OPIATED SUBSTANCES ROLABO SL (ES) 1998-01-07 — — EP disclosed
WO-1993024505-A1 REDUCING INFLAMMATION BY TIME DEPENDENT ADMINISTRATION OF OLIGOSACCHARIDES GLYCOSIDES RELATED TO BLOOD GROUP DETERMINANTS ALBERTA RESEARCH COUNCIL (CA) 1993-12-09 — — WO disclosed
EP-0549665-A1 POLY(FLUOROALKYL) SUGAR REAGENTS AND THEIR USE FOR SURFACE MODIFICATION E.I. DU PONT DE NEMOURS AND COMPANY (US) 1993-07-07 — — EP disclosed
WO-1992005444-A1 POLY(FLUOROALKYL) SUGAR REAGENTS AND THEIR USE FOR SURFACE MODIFICATION E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-04-02 — — WO disclosed
Send feedback